KUALA LUMPUR: Ekuiti Nasional Bhd (Ekuinas) has acquired an 80% stake in Symbiotica Speciality Ingredients Sdn Bhd, a leading homegrown active pharmaceutical ingredient (API) manufacturer in South-East Asia (SEA).
Ekuinas chief executive officer Datuk Syed Yasir Arafat Syed Abd Kadir said the pharmaceutical industry is a significant economic contributor with remarkable growth potential.
Already a subscriber? Log in
The Star 6.6 DEAL: 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
